Ledipasvir, CAS [[1256388-51-8]], Unconjugated

Produktübersicht

• Artikelname: Ledipasvir, CAS [[1256388-51-8]], Unconjugated
• Artikelnummer: BSS-BS-6438C
• Hersteller Artikelnummer: bs-6438C
• Alternativnummer: BSS-BS-6438C-10,BSS-BS-6438C-2
• Hersteller: Bioss
• Kategorie: Biochemikalien
• Konjugation: Unconjugated

Produktbeschreibung

Ledipasvir, also known as GS-5885, is an inhibitor of the hepatitis C virus NS5A protein and is a drug for the treatment of hepatitis C that was developed by Gilead Sciences. On October 10, 2014 the FDA approved the combination product ledipasvir 90 mg/sofosbuvir 400 mg (trade name Harvoni). The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin. (http://en.wikipedia.org/wiki/Ledipasvir)

Produkteigenschaften

• Puffer: Powder
• CAS Nummer: [1256388-51-8]